AMPX vs HUBG

AMPX exhibits weak deterministic health with a Piotroski F-Score of 1/9, indicating severe financial distress and poor operational efficiency, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite this, the stock is trading at a premium valuation (Forward P/E: 182.91, Price/Sales: 33.78) driven by extraordinary revenue growth (137.4% YoY) and strong earnings surprises (average +52.81% over last 4 quarters). Analyst consensus is strongly bullish with a 'strong_buy' rating and a $20.00 target, reflecting high growth expectations. Insider selling activity (8 transactions, $37.78M) introduces bearish sentiment, but the company's technical trend and recent price momentum suggest strong market confidence. The Graham Number and intrinsic value are unavailable, indicating no defensive margin of safety.

HUBG exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very conservative debt-to-equity ratio of 0.28. While the current price of $38.97 sits above the defensive Graham Number ($33.01), it remains well below the growth-based intrinsic value of $51.33. The company is successfully expanding margins, as evidenced by 20.5% earnings growth despite a 5.3% decline in revenue. Despite bearish technicals and recent insider selling, the long-term earnings track record and valuation metrics suggest significant upside.